Health
EU regulator backs GSK’s bone marrow cancer treatment
British drugmaker GSK said the European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of its oral therapy to treat anaemia
Accord Healthcare restarts production of cancer drug cisplatin amid shortages
The US Food and Drug Administration said Accord Healthcare has restarted production of the widely used cancer drug cisplatin amid ongoing drug shortages in the
Novo says Wegovy’s heart benefits are not due to weight loss alone
Novo Nordisk said the cardioprotective benefits of its anti-obesity treatment Wegovy are due to more than just weight loss. Wegovy helps patients lose an average
AstraZeneca prioritises RSV drug in the US
AstraZeneca said it was prioritising the US market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was approved in July to
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
Novo Nordisk shares rose 3% on Monday as the market reacted to data presented by the drugmaker over the weekend showing that the protective effect
EU backs GSK’s bone marrow cancer therapy
UK drugmaker GSK said the European Medicines Agency’s human medicines committee had recommended approving its oral therapy to treat anaemia in patients with a type
Novo to invest $6 billion in Wegovy production facility
Obesity drug maker Novo Nordisk has said it will spend $6bn to boost production in Denmark, although its chief executive has warned that the industry
Mirati’s lung cancer drug has received regulatory support from the EU
Mirati Therapeutics said a committee of the European medicines regulator has recommended approval of its treatment for a type of lung cancer. A committee of
Surgeons in New York have announced the world’s first eye transplant
Surgeons in New York have performed the first-ever transplant of an entire eye into a person, they announced Thursday. The achievement has been hailed as
The injectable drug Eisai for Alzheimer’s disease works the same as intravenous Leqembi
An injectable version of Eisai and Biogen’s Alzheimer’s disease drug Leqembi works just as well as the existing intravenous version at removing toxic plaques in